Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$738,494,723
-$127,600,434 QoQ
Shares Held
2,907,803
-17.9% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#77
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $6,352,612,055 across 16 Drug Manufacturers - General names. JNJ ranks #4 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
27,357,486 | $1,576,338,337 | |
| 2 | LLY |
ELI LILLY & Co
|
1,035,605 | $1,242,135,802 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,134,262 | $1,045,252,665 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
2,907,803 | $738,494,723 | |
| 5 | ABBV |
AbbVie Inc.
|
2,015,238 | $507,114,486 | |
| 6 | PFE |
Pfizer Inc
|
18,557,891 | $446,874,011 | |
| 7 | BIIB |
Biogen Inc.
|
1,936,859 | $418,477,751 | |
| 8 | AMGN |
Amgen Inc
|
300,007 | $108,638,532 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $738,494,723 | 2,907,803 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $866,095,157 | 3,543,181 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $802,183,932 | 3,876,221 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $802,210,727 | 4,326,452 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $732,510,943 | 4,795,489 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $873,265,343 | 5,265,710 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $502,212,471 | 3,472,635 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $511,941,541 | 3,158,963 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $489,678,677 | 3,350,292 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $382,474,153 | 2,417,815 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $293,418,846 | 1,872,010 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $234,564,639 | 1,506,033 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $250,831,986 | 1,515,418 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $308,543,465 | 1,990,603 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $326,155,784 | 1,846,339 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $326,258,671 | 1,997,176 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $372,360,774 | 2,097,689 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $528,144,690 | 2,979,996 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $510,823,572 | 2,986,050 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $491,892,016 | 3,045,771 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $513,112,052 | 3,114,678 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $674,191,145 | 4,102,167 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $677,137,836 | 4,302,566 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $714,403,210 | 4,798,517 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $748,572,785 | 5,322,995 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $792,316,831 | 6,042,224 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||